New distribution! Reach relevant USA TODAY Network news sites. Get started ›

New distribution! Reach relevant USA TODAY Network news sites. Get started ›

World Media Directory · RSS · Email Newsletters

There were 1,238 press releases posted in the last 24 hours and 457,471 in the last 365 days.

Press Releases on September 17, 2018

1,839 Press Releases

Published on September 17, 2018 - 12:16 GMT

Human medicines European public assessment report (EPAR): Edistride, dapagliflozin, Diabetes Mellitus, Type 2;Heart Failure, ...

Type 2 diabetes Edistride was found effective in several studies in patients with type 2 diabetes. The main measure of effectiveness was the level of glycosylated haemoglobin (HbA1c), which gives an indication of how well blood glucose is controlled. In …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on September 17, 2018 - 12:16 GMT

United Kingdom Article IV Press Conference

Managing Director’s Opening Remarks September 17, 2018 Dear Chancellor, thank you very much for your kind introduction. Ladies and gentlemen, good morning. It’s always a pleasure to be in London. We are here for our annual review of the British economy …

Distribution channels: Banking, Finance & Investment Industry
Published on September 17, 2018 - 12:16 GMT

Procurement

Tenders worth €140,000 or more EMA usually follows an open procedure for tenders worth €140,000 or more. EMA may also publish a prior information notice (PIN) to indicate that it intends to launch an open call for tenders in the future. Publishing a PIN in …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on September 17, 2018 - 12:16 GMT

Opinion/decision on a Paediatric investigation plan (PIP): Recombinant human A disintegrin and metalloprotease with thrombospind ...

For the United Kingdom, as of 1 January 2021, European Union law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland / NI.

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on September 17, 2018 - 12:16 GMT

Human medicines European public assessment report (EPAR): Ecansya (previously Capecitabine Krka), capecitabine, Colonic Neoplasms;...

Ecansya is indicated for the adjuvant treatment of patients following surgery of stage-III (Dukes’ stage-C) colon cancer. Ecansya is indicated for the treatment of metastatic colorectal cancer. Ecansya is indicated for first-line treatment of advanced …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on September 17, 2018 - 12:16 GMT

Human medicines European public assessment report (EPAR): Ecansya (previously Capecitabine Krka), capecitabine, Colonic Neoplasms;...

Ecansya is indicated for the adjuvant treatment of patients following surgery of stage-III (Dukes’ stage-C) colon cancer. Ecansya is indicated for the treatment of metastatic colorectal cancer. Ecansya is indicated for first-line treatment of advanced …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on September 17, 2018 - 12:15 GMT

Human medicines European public assessment report (EPAR): Xerava, eravacycline, Infection;Bacterial Infections, Date of ...

Xerava was shown to be as effective as alternative antibiotics in 2 main studies of adults with cIAIs. The main measure of effectiveness in both studies was whether the infection was cured. In the first study involving 538 patients, Xerava was compared …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on September 17, 2018 - 12:15 GMT

Human medicines European public assessment report (EPAR): Xerava, eravacycline, Infection;Bacterial Infections, Date of ...

Xerava was shown to be as effective as alternative antibiotics in 2 main studies of adults with cIAIs. The main measure of effectiveness in both studies was whether the infection was cured. In the first study involving 538 patients, Xerava was compared …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on September 17, 2018 - 12:15 GMT

Article 5 procedure: Regulatory and procedural guidance

For the United Kingdom, as of 1 January 2021, European Union law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland / NI.

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on September 17, 2018 - 12:15 GMT

Human medicines European public assessment report (EPAR): Tasigna, nilotinib, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, ...

Tasigna is a medicine for treating chronic myelogenous leukaemia (CML) – a blood cancer – in patients who have been newly diagnosed or who cannot take other cancer medicines (including imatinib) because they cause side effects or do not work for them. …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on September 17, 2018 - 12:15 GMT

Human medicines European public assessment report (EPAR): Tasigna, nilotinib, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, ...

Tasigna is a medicine for treating chronic myelogenous leukaemia (CML) – a blood cancer – in patients who have been newly diagnosed or who cannot take other cancer medicines (including imatinib) because they cause side effects or do not work for them. …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on September 17, 2018 - 12:15 GMT

Orphan designation: Delta-9-tetrahydrocannabinol and cannabidiol from extracts of the Cannabis sativa L. plant, Treatment of ...

Glioma is a type of brain tumour that affects the 'glial' cells (the cells that surround and support the nerve cells). Patients with glioma can have severe symptoms, but the types of symptoms experienced depend on where the tumour develops in the …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on September 17, 2018 - 12:15 GMT

Human medicines European public assessment report (EPAR): Nitisinone MDK (previously Nitisinone MendeliKABS), nitisinone, ...

Unit 3D, North Point House North Point Business Park New Mallow Road Cork, T23 AT2P, Ireland

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on September 17, 2018 - 12:15 GMT

Human medicines European public assessment report (EPAR): Nitisinone MDK (previously Nitisinone MendeliKABS), nitisinone, ...

Unit 3D, North Point House North Point Business Park New Mallow Road Cork, T23 AT2P, Ireland

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on September 17, 2018 - 12:15 GMT

Human medicines European public assessment report (EPAR): Tysabri, natalizumab, Multiple Sclerosis, Date of authorisation: 27/06/...

Tysabri can increase the risk of infections, including the brain infection PML. PML is a very serious condition that may result in severe disability or death. The risk of PML increases the longer a patient has been receiving Tysabri, especially in patients …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on September 17, 2018 - 12:15 GMT

Human medicines European public assessment report (EPAR): Tysabri, natalizumab, Multiple Sclerosis, Date of authorisation: 27/06/...

Tysabri can increase the risk of infections, including the brain infection PML. PML is a very serious condition that may result in severe disability or death. The risk of PML increases the longer a patient has been receiving Tysabri, especially in patients …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on September 17, 2018 - 12:15 GMT

PRIME: priority medicines

EMA's 5-year report on the PRIME scheme provides a detailed analysis and review of the Agency's experience with the scheme in its first five years of application. It looks at how the scheme helped developers prepare for marketing authorisation …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on September 17, 2018 - 12:15 GMT

Human medicines European public assessment report (EPAR): Levetiracetam Actavis Group, levetiracetam, Epilepsy, Date of ...

Levetiracetam Actavis Group is an epilepsy medicine. It can be used on its own in patients from 16 years of age with newly diagnosed epilepsy, to treat partial-onset seizures (fits) with or without secondary generalisation. This is a type of epilepsy where …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on September 17, 2018 - 12:15 GMT

Human medicines European public assessment report (EPAR): Levetiracetam Actavis Group, levetiracetam, Epilepsy, Date of ...

Levetiracetam Actavis Group is an epilepsy medicine. It can be used on its own in patients from 16 years of age with newly diagnosed epilepsy, to treat partial-onset seizures (fits) with or without secondary generalisation. This is a type of epilepsy where …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on September 17, 2018 - 12:15 GMT

Human medicines European public assessment report (EPAR): Siklos, hydroxycarbamide, Anemia, Sickle Cell, Date of authorisation: 29/...

Siklos is used in adults, adolescents and children over two years of age who have sickle-cell syndrome, a genetic disease where the red blood cells become rigid and sticky, and change from being disc-shaped to being crescent-shaped (like a sickle). It is …

Distribution channels: Healthcare & Pharmaceuticals Industry

Previous 31 32 33 34 35 36 37 38 39 40 41 Next

Previous Day 2018 Calendar Next Day